Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels
Today’s guest post comes from Laura Jensen, Chief Commercial Officer and President, Pharma Direct at GoodRx. Laura suggests that manufacturers must move beyond payer-centric models toward integrated, direct-to-consumer and employer channel strategies that connect pricing, demand, and fulfillment. Sh
By Drug Channels
· Apr 24, 2026
· via Drug Channels
Tags
negotiationsformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from Negotiations
All Negotiations →
NegotiationsBriefing
Bansi Nagji says rare disease pharmacies must rethink every assumption of traditional specialty models, from s…
Negotiations
The 2026 FTC settlement compels Express Scripts to base patient costs on net, not list, prices—ending the reba…
Negotiations
AssistRx says half of its 2025 patient support programs came via hub transitions, underscoring deep vendor con…